MedHub-AI

0 reviews

MedHub-AI, established in 2018, specializes in developing AI-driven solutions to enhance precision in cardiac care. Their flagship product, AutocathFFR™, is the world's first fully automated, AI-based diagnostic tool designed for interventional cardiologists. This system delivers Fractional Flow Reserve (FFR) results in just 37 seconds, enabling real-time assessment of coronary artery stenosis and facilitating evidence-based revascularization strategies. Key Features and Functionality: - Rapid, Non-Invasive FFR Analysis: Provides quick and seamless image-based FFR measurements without the need for invasive procedures. - Automated Stenosis Detection and Classification: Utilizes AI to identify and categorize arterial narrowings accurately. - Real-Time Stenosis Tracking: Offers continuous monitoring of stenosis progression during procedures. - Offline Operation Capability: Functions effectively without requiring an internet connection, ensuring reliability in various clinical settings. MedHub-AI's technology addresses critical challenges in cardiology by reducing post-procedure adverse events and mortality rates, preventing unnecessary therapeutic interventions, and minimizing additional invasive diagnostics. By integrating AI into cardiac care, MedHub-AI enhances clinical decision-making, improves patient outcomes, and streamlines workflows for healthcare providers.